The Board of Directors of Karo Bio has decided to convene an Extraordinary
General Meeting on November 19, 2012 and there present a proposal to implement a
rights issue of approximately MSEK 38.7 with preferential rights for existing
shareholders. The purpose of the issue is to secure funding that will allow the
company to achieve a neutral cash flow, which is expected to be within reach in
2013.
